Added Prognostic Value of Cerebrospinal Fluid Biomarkers in Predicting Decline in Memory Clinic Patients in a Prospective Cohort

Ron L. H. Handels*, Manuela A. Joore, Stephanie J. B. Vos, Pauline Aalten, Inez H. G. B. Ramakers, Marcel Olde Rikkert, Philip Scheltens, Willemijn J. Jansen, Pieter-Jelle Visser, Bart M. N. van Berckel, Peter van Domburg, Machiel Smid, Erik Hoff, Jan Hoogmoed, Femke Bouwman, Jurgen Claassen, Albert F. G. Leentjens, Claire A. G. Wolfs, Johan L. Severens, Frans R. J. Verhey

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)875-885
JournalJournal of Alzheimer's Disease
Volume52
Issue number3
DOIs
Publication statusPublished - 2016

Keywords

  • Alzheimer's disease
  • cerebrospinal fluid
  • memory disorders
  • mild cognitive impairment
  • prognosis
  • sensitivity and specificity

Cite this